Ander H, Donmez MI, Yitgin Y, Tefik T, Ziylan O, Oktar T, Ozsoy M. Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up. Int Urol

Yitgin Y, Erdem S, Serilmez M, Duranyıldız D, Verep S, Gasimov K, Tefik T, Sanli O, Ozcan F. Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?

Karakose A, Yitgin Y. Penile Rehabilitation with Low-intensity Extracorporeal Shock Wave Therapy in Patients After Prostate Cancer Surgery. Early Physiological Changes and Postoperative Follow-up Outcomes.

Yitgin Y, Yitgin E, Verep S, Gasimov K, Tefik T, Karakose A. Is Access Sheath Essential for Safety and Effective Retrograde Intrarenal Stone Surgery? J Coll Physicians Surg Pak 2021 Oct;31(10):1202-1206. 6.1.5. Karakose A, Yitgin Y. A clinical trial comparing BiVap (Richard Wolf®) saline vaporization of the prostate vs. TwisterTM Diode Laser System in the treatment of benign prostatic obstruction between prostate volume 90 to 150 ml.

Yitgin Y, Altınkaya N, Turaliev N, Guven S, Ergul RB, Boyuk A, Verep S, Tefik T, Karagoz MA, Ibis MA, Gokce MI, Sarıca K. Evaluation of the optimal duration for retrograde intrarenal stone surgery to prevent postoperative complications.

Ibis MA, Gokce MI, Babayigit M, Yitgin Y, Karagoz MA, Boyuk A, Verep S, Turan S, Tefik T, Kiremit MC, Sonmez MG, Ergul R, Guven S, Sarica K. Could retrograde intrarenal surgery be a safe and effective alternative to mini-percutaneous nephrolithotomy ın the management of relatively large (20-30 mm) stones? A critical evaluation.

Karagöz MA, Güven S, Tefik T, Gökçe Mİ, Kiremit MC, Atar FA, İbiş MA, Yitgin Y, Böyük A, Verep S, Sarıca K. Attitudes of urologists on metabolic evaluation for urolithiasis: outcomes of a global survey from 57 countries. Urolithiasis.

Yitgin Y, Asrak H, Tefik T. Role, importance and assessment of dietary habits in urolithiasis patient.

İbis MA, Gokce MI, Gökhan O, Karagoz MA, Yitgin Y, Babayigit M, Böyük A, Verep S, Tefik T, Kiremit MC, Senocak C, Guven S, Sarica K. What Is the Ideal Treatment for 20-30 mm Kidney Stones? Comparative Outcomes of 1197 Patients.

Yitgin Y, Karakose A. Correlation of resistive index of prostatic capsular artery to clinical symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Lower urinary tract symptoms vol.

Karakose A, Yitgin Y. “A new alternative approach to management of acute phase Peyronie's disease: low intensity extracorporeal shockwave therapy and platelet-rich plasma.” Minerva urology and nephrology,

. Tefik Tzevat, Yitgin Yasin, Ture Muhammet, Demircan Volkan, Erdem Selcuk, Oktar Tayfun Mevlut, Sanli Mehmet Oner, Kocak Taner, Nane Ismet. The assesment of success rates of retrograd intrarenal surgery in nephrolithiazis patients: The predictive value of the Resorlu, Seoul and Ito nomograms.

Yasin Yitgin, Samed Verep, Mihriban Yagci, Selcuk Erdem, Atadan Tunaci, Faruk Ozcan. Incidence of High Risk Prostate Cancer in Prostate Biopsies According to PIRADS V2 Classification.

Samed Verep, Selcuk Erdem, Yasin Yitgin, Tzevat Tefik, Yasemin Ozluk, Oner Sanli, Faruk Ozcan. The pathological upgrading and upstaging after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?

Selcuk Erdem, Samed Verep, Yasin Yitgin, Baris Aydin, Atadan Tunaci, Haluk Ander, Oner Sanli, Faruk Ozcan. The concordance between prostate cancer core sites in cognitive systematic biopsy and the localization of suspicious lesions at multiparametric prostate magnetic resonance imaging: A preliminary report.

Selcuk Erdem, Samed Verep, Yasin Yitgin, Baris Aydin, Merve Gulbiz Kartal, Atadan Tunaci, Haluk Ander, Oner Sanli, Faruk Ozcan. Does it matter who perform multiparametric magnetic resonance imaging directed cognitive prostate biopsy to detect prostate cancer? The comparison of urologists and radiologists

Erdem S, Ozcan F, Yitgin Y, Verep S, Aydin B, Tunaci A, Ander H, Sanli O. The relationship between PIRADSv2 scores and the incidence of prostate cancer in cognitive prostate biopsies.

Yitgin Y, Altınkaya N, Turaliev N, Guven S, Ergul R.B, Boyuk A, Verep S, Tefik T, Karagoz M.A, Ibis M.A, Gokce M.I, Sarica K. Evaluation of the optimal duration for retrograde intrarenal stone surgery to prevent postoperative complications.

Yitgin Y, Karakose A. Retrograde intrarenal surgery without DJ stent placement in selected cases of renal stones of 1 cm or less. A preliminary study.

Karagöz M.A, Güven S, Tefik T, Gökçe M.I, Kiremit M.C, Ibis A, Yitgin Y, Böyük E, Verep S, Sarica K. Why do urologists avoid metabolic evaluation for stone recurrence?

Ibis M.A, Gokce M, Babayigit M, Yitgin Y, Karagoz M.A, Boyuk A, Verep S, Turan S, Tefik T, Kiremit M.C, Sonmez M.G, Ergul R, Guven S, Sarica K. Could retrograde intrarenal surgery be a safe and effective alternative to mini percutaneous nephrolithotomy in the management of relatively large (20-30 mm) stones?

Yitgin Y, Ergul R.B, Tefik T. Tranexamic Acid in Challenging Stone Cases of Retrograde Intrarenal Surgery. a Preliminary Study.